FDA Set to OK Period Suppression Pill

May 19, 2007 By LINDA A. JOHNSON, AP Business Writer FDA Set to OK Period Suppression Pill (AP)

Women looking for a simple way to avoid their menstrual period could soon have access the first birth control pill designed to let women suppress monthly bleeding indefinitely. The U.S. Food and Drug Administration is expect to announce approval Tuesday for Lybrel, a drug from Wyeth which would be the first pill to be taken continuously. (AP Graphic)

(AP) -- Women looking for a simple way to avoid their menstrual period could soon have access the first birth control pill designed to let women suppress monthly bleeding indefinitely.

Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit www.ap.org .

Similar stories from PHYSorg:

TV Drama Can be More Persuasive Than News Program, Study Finds

Feb 08, 2010 | not rated yet | 0

The Shoulders of Giants

Feb 08, 2010 | 5 / 5 (3) | 3

Herbal medicines can be lethal, pathologist warns

Feb 08, 2010 | not rated yet | 3

Gadgets: Give a gadget for Valentine's Day

Feb 05, 2010 | not rated yet | 0

Are Multivitamins Worth the Money?

Feb 04, 2010 | 2.5 / 5 (11) | 0

Rate this story - 3.9 /5 (9 votes)

rank
1
2
3
4
5

view popular

Other News

Early life stress may predict cardiovascular disease

Medicine & Health / Health

24 minutes ago | not rated yet | 0 |

Early life stress could be a risk factor for cardiovascular disease in adulthood, researchers report.

Babies wise to what we really mean: Researchers find first evidence that six-month-olds comprehend adults' intentions

Medicine & Health / Psychology & Psychiatry

42 minutes ago | not rated yet | 0 |

A study by York University researchers reveals that infants as young as six months old know when we're "playing" them - and they don't like it.

Predicting effectiveness of flu vaccination campaigns

Medicine & Health / Research

42 minutes ago | not rated yet | 0

A new study, published by Elsevier this month in Vaccine, describes a new method that assesses the impact and cost-effectiveness of a range of vaccination options. The model was applied to the 2009 Influenza H1N1 outbreak and pr ...

Study: End-of-life care must reflect patient wishes and values

Medicine & Health / Health

22 minutes ago | not rated yet | 0

Researchers from Brown University and Harvard Medical School are calling for improved decision-making in the use of feeding tubes for hospitalized nursing home residents with advanced dementia.

The biggest loser: Maternal obesity puts a load on her offspring that lasts a lifetime

Medicine & Health / Health

32 minutes ago | not rated yet | 0

As if there are not enough reasons for obese people to lose weight, a new research report published online in The FASEB Journal, adds several more. In a study involving rats, researchers from Duke University found that obesity ...